• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    US Stocks Turn Lower; Dow Drops 150 Points

    2/23/23 12:25:55 PM ET
    $CYRN
    $INFI
    $LHDX
    $NEO
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $CYRN alert in real time by email

    U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 150 points on Thursday.

    The Dow traded down 0.47% to 32,889.30 while the NASDAQ fell 0.47% to 11,452.63. The S&P 500 also fell, dropping, 0.32% to 3,978.24.

    Check This Out: Wall Street's Most Accurate Analysts Say Hold These 3 Healthcare Stocks Delivering High-Dividend Yields

     

    Leading and Lagging Sectors

    • Energy shares rose around 0.7% on Thursday. Meanwhile, top gainers in the sector included Permian Resources Corporation (NYSE:PR), up 14%, and Obsidian Energy Ltd. (NYSE:OBE), up 10%.
    • In trading on Thursday, communication services shares fell by 1.6%.

     

    Top Headline

    US jobless claims dropped by 3,000 to 192,000 in the week ending Feb. 18, compared to market estimates of 200,000.

     

    Equities Trading UP

    • Ocean Biomedical, Inc. (NASDAQ:OCEA) shares shot up 230% to $15.87 after the company issued a press release celebrating the discovery of bispecific antibodies and immune checkpoint inibitors that kill glioblastoma cells and melanoma cells and block the metastasis of malignant melanoma cells to the lung by over 90%.
    • Shares of NeoGenomics, Inc. (NASDAQ:NEO) got a boost, shooting 21% to $16.22 after reporting better-than-expected Q4 results.
    • Vascular Biogenics Ltd. (NASDAQ:VBLT) shares were also up, gaining 75% to $0.2269 after the company and Notable Labs announced a definitive merger agreement.

     

    Equities Trading DOWN

    • Cyren Ltd. (NASDAQ:CYRN) shares tumbled 40% to $0.23 after the company announced it will be delisted from the Nasdaq.
    • Shares of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) were down 46% to $0.2981 after the company and MEI Pharma announced a definitive merger agreement to advance three promising clinical oncology candidates. Infinity will become a wholly owned subsidiary of MEI Pharma.
    • Lucira Health, Inc. (NASDAQ:LHDX) was down, falling 37% to $0.1439 after the company announced it will pursue a strategic sale of its business through the voluntary Chapter 11 process.

    Also Check This Out: Bitcoin, Ethereum Move Higher; Optimism, Enjin Coin Among Top Gainers

     

    Commodities

    In commodity news, oil traded up 1.5% to $75.08 while gold traded down 0.7% at $1,828.70.

    Silver traded down 1.6% to $21.34 on Thursday while copper fell 3% to $4.0665.

    Stocks of crude oil in the US rose by 9.895 million barrels in the week ended Feb. 17, 2023, data from the American Petroleum Institute showed. Stocks of crude oil in the US climbed by 7.648 million barrels to 850.6 million in the week ended Feb. 17, 2023, the EIA said.

     

    Euro zone

    European shares were mostly higher today. The eurozone’s STOXX 600 rose 0.13%, London’s FTSE 100 dropped 0.24% while Spain’s IBEX 35 Index rose 0.62%. The German DAX gained 0.56% French CAC 40 rose 0.36% and Italy’s FTSE MIB Index climbed 0.73%.

    The consumer price inflation in the Eurozone rose to 8.6% year-over-year in January from a preliminary reading of 8.5%.

     

    Asia Pacific Markets

    Asian markets closed lower on Thursday, with Hong Kong’s Hang Seng Index falling 0.35% and China’s Shanghai Composite Index dropping 0.11%. India’s S&P BSE Sensex dropped 0.1%.

    The annual inflation rate in Hong Kong increased to 2.4% in January from 2% in the prior month, while Singapore’s annual inflation rate rose to 6.6% in January.

     

    Economics

    • US jobless claims dropped by 3,000 to 192,000 in the week ending Feb. 18, compared to market estimates of 200,000.
    • The US economy grew by an annualized 2.7% on quarter during the fourth quarter, down from 2.9% in the advance estimate.
    • The Chicago Fed National Activity Index climbed to +0.23 in January versus a revised reading of -0.46 in December.
    • Stocks of crude oil in the US climbed by 7.648 million barrels to 850.6 million in the week ended Feb. 17, 2023, the EIA said.
    • The Kansas City Fed’s Manufacturing Production index declined to -9 in February from -4 a month ago.

    Now Read This: Top 5 Energy Stocks Which Could Rescue Your Portfolio This Month

     

    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 105,092,400 cases with around 1,143,760 deaths. India confirmed a total of at least 44,685,450 cases and 530,760 deaths, while France reported over 39,600,540 COVID-19 cases with 164,820 deaths. In total, there were at least 679,159,550 cases of COVID-19 worldwide with more than 6,794,390 deaths.

    Get the next $CYRN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CYRN
    $INFI
    $LHDX
    $NEO

    CompanyDatePrice TargetRatingAnalyst
    Permian Resources Corporation
    $PR
    1/16/2026$16.00Buy → Neutral
    BofA Securities
    Permian Resources Corporation
    $PR
    9/19/2025$21.00Sector Outperform
    Scotiabank
    Permian Resources Corporation
    $PR
    8/25/2025Outperform
    William Blair
    NeoGenomics Inc.
    $NEO
    7/30/2025Buy → Neutral
    BTIG Research
    NeoGenomics Inc.
    $NEO
    7/29/2025Outperform → Mkt Perform
    William Blair
    NeoGenomics Inc.
    $NEO
    5/15/2025Neutral
    Guggenheim
    NeoGenomics Inc.
    $NEO
    4/30/2025$9.00Outperform → Market Perform
    Leerink Partners
    Obsidian Energy Ltd.
    $OBE
    4/17/2025Sector Perform
    RBC Capital Mkts
    More analyst ratings

    $CYRN
    $INFI
    $LHDX
    $NEO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Permian Resources downgraded by BofA Securities with a new price target

    BofA Securities downgraded Permian Resources from Buy to Neutral and set a new price target of $16.00

    1/16/26 8:36:55 AM ET
    $PR
    Oil & Gas Production
    Energy

    Scotiabank initiated coverage on Permian Resources with a new price target

    Scotiabank initiated coverage of Permian Resources with a rating of Sector Outperform and set a new price target of $21.00

    9/19/25 8:38:19 AM ET
    $PR
    Oil & Gas Production
    Energy

    William Blair initiated coverage on Permian Resources

    William Blair initiated coverage of Permian Resources with a rating of Outperform

    8/25/25 8:22:28 AM ET
    $PR
    Oil & Gas Production
    Energy

    $CYRN
    $INFI
    $LHDX
    $NEO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Pres & Chief Operating Officer Stone Warren sold $276,682 worth of shares (22,128 units at $12.50), decreasing direct ownership by 15% to 121,631 units (SEC Form 4)

    4 - NEOGENOMICS INC (0001077183) (Issuer)

    1/21/26 9:01:45 PM ET
    $NEO
    Precision Instruments
    Health Care

    Pres & Chief Operating Officer Stone Warren converted options into 59,382 shares and covered exercise/tax liability with 15,127 shares, increasing direct ownership by 44% to 143,759 units (SEC Form 4)

    4 - NEOGENOMICS INC (0001077183) (Issuer)

    1/15/26 4:22:44 PM ET
    $NEO
    Precision Instruments
    Health Care

    EVP, GC & Business Development Olivo Alicia C converted options into 59,382 shares and covered exercise/tax liability with 15,145 shares, increasing direct ownership by 142% to 75,320 units (SEC Form 4)

    4 - NEOGENOMICS INC (0001077183) (Issuer)

    1/15/26 4:22:08 PM ET
    $NEO
    Precision Instruments
    Health Care

    $CYRN
    $INFI
    $LHDX
    $NEO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Obsidian Energy Announces Strong 2025 Reserves Results

    Reserve replacement of 118 percent, 185 percent and 235 percent of 2025 production (adjusted for dispositions) on a proved developed producing ("PDP"), proved ("1P"), and proved plus probable("2P") reserves basisAdded locations in the Willesden Green (Belly River) in both Crimson and Open Creek based on 2025 successInitial waterflood reserve bookings from recent pilots at Peace River in the ClearwaterCalgary, Alberta--(Newsfile Corp. - February 5, 2026) - OBSIDIAN ENERGY LTD. (TSX:OBE) (NYSE:OBE) ("Obsidian Energy", the "Company", "we", "us" or "our") is pleased to announce the results of our independent reserves evaluation for the year ended December 31, 2025 (the "2025 Reserve Report") pre

    2/5/26 7:00:00 AM ET
    $OBE
    Oil & Gas Production
    Energy

    NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026

    NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its fourth quarter and full year 2025 financial results prior to the open of the U.S. financial markets on Tuesday, February 17, 2026. Company management will host a webcast and conference call at 8:30 a.m. ET to discuss financial results and recent highlights. The live webcast may be accessed by visiting the Investor Relations section of our website at ir.neogenomics.com or by clicking here. The webcast will be archived and available for replay shortly after the conclusion of the call. To access the live call via telephone, dial (888) 5

    1/27/26 7:05:00 AM ET
    $NEO
    Precision Instruments
    Health Care

    Permian Resources Announces Fourth Quarter and Full Year 2025 Earnings Conference Call

    Permian Resources Corporation ("Permian Resources" or the "Company") (NYSE:PR) announced today that it will report fourth quarter and full year 2025 financial and operating results after the market closes for trading on Wednesday, February 25, 2026. Management will host an earnings conference call on Thursday, February 26, 2026, at 9:00 a.m. Central (10:00 a.m. Eastern). Interested parties are invited to participate on the call by dialing (800) 549-8228 (Conference ID: 23999) at least 15 minutes prior to the start of the call or via the internet at www.permianres.com. A replay of the call will be available on the Company's website or by phone at (888) 660-6264 (Passcode: 23999) for a 14-day

    1/23/26 7:00:00 AM ET
    $PR
    Oil & Gas Production
    Energy

    $CYRN
    $INFI
    $LHDX
    $NEO
    SEC Filings

    View All

    SEC Form 6-K filed by Obsidian Energy Ltd.

    6-K - OBSIDIAN ENERGY LTD. (0001334388) (Filer)

    2/5/26 12:51:35 PM ET
    $OBE
    Oil & Gas Production
    Energy

    SEC Form 6-K filed by Obsidian Energy Ltd.

    6-K - OBSIDIAN ENERGY LTD. (0001334388) (Filer)

    2/2/26 12:11:04 PM ET
    $OBE
    Oil & Gas Production
    Energy

    SEC Form 6-K filed by Obsidian Energy Ltd.

    6-K - OBSIDIAN ENERGY LTD. (0001334388) (Filer)

    1/22/26 11:58:27 AM ET
    $OBE
    Oil & Gas Production
    Energy

    $CYRN
    $INFI
    $LHDX
    $NEO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Sherman Jeffrey Scott bought $112,322 worth of shares (20,000 units at $5.62), increasing direct ownership by 12% to 188,332 units (SEC Form 4)

    4 - NEOGENOMICS INC (0001077183) (Issuer)

    8/6/25 4:07:57 PM ET
    $NEO
    Precision Instruments
    Health Care

    Chief Executive Officer Zook Anthony P. bought $99,954 worth of shares (17,900 units at $5.58), increasing direct ownership by 89% to 38,066 units (SEC Form 4)

    4 - NEOGENOMICS INC (0001077183) (Issuer)

    8/6/25 4:07:25 PM ET
    $NEO
    Precision Instruments
    Health Care

    Director Kelly Michael Aaron bought $38,000 worth of shares (5,000 units at $7.60) (SEC Form 4)

    4 - NEOGENOMICS INC (0001077183) (Issuer)

    5/28/25 4:07:40 PM ET
    $NEO
    Precision Instruments
    Health Care

    $CYRN
    $INFI
    $LHDX
    $NEO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by NeoGenomics Inc.

    SC 13G/A - NEOGENOMICS INC (0001077183) (Subject)

    11/14/24 1:28:29 PM ET
    $NEO
    Precision Instruments
    Health Care

    SEC Form SC 13D filed by Obsidian Energy Ltd.

    SC 13D - OBSIDIAN ENERGY LTD. (0001334388) (Subject)

    11/7/24 8:07:08 PM ET
    $OBE
    Oil & Gas Production
    Energy

    Amendment: SEC Form SC 13D/A filed by Permian Resources Corporation

    SC 13D/A - Permian Resources Corp (0001658566) (Subject)

    6/21/24 4:05:39 PM ET
    $PR
    Oil & Gas Production
    Energy

    $CYRN
    $INFI
    $LHDX
    $NEO
    Financials

    Live finance-specific insights

    View All

    NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026

    NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its fourth quarter and full year 2025 financial results prior to the open of the U.S. financial markets on Tuesday, February 17, 2026. Company management will host a webcast and conference call at 8:30 a.m. ET to discuss financial results and recent highlights. The live webcast may be accessed by visiting the Investor Relations section of our website at ir.neogenomics.com or by clicking here. The webcast will be archived and available for replay shortly after the conclusion of the call. To access the live call via telephone, dial (888) 5

    1/27/26 7:05:00 AM ET
    $NEO
    Precision Instruments
    Health Care

    Permian Resources Announces Fourth Quarter and Full Year 2025 Earnings Conference Call

    Permian Resources Corporation ("Permian Resources" or the "Company") (NYSE:PR) announced today that it will report fourth quarter and full year 2025 financial and operating results after the market closes for trading on Wednesday, February 25, 2026. Management will host an earnings conference call on Thursday, February 26, 2026, at 9:00 a.m. Central (10:00 a.m. Eastern). Interested parties are invited to participate on the call by dialing (800) 549-8228 (Conference ID: 23999) at least 15 minutes prior to the start of the call or via the internet at www.permianres.com. A replay of the call will be available on the Company's website or by phone at (888) 660-6264 (Passcode: 23999) for a 14-day

    1/23/26 7:00:00 AM ET
    $PR
    Oil & Gas Production
    Energy

    Permian Resources Declares Quarterly Cash Dividend

    Permian Resources Corporation ("Permian Resources" or the "Company") (NYSE:PR) today announced that its Board of Directors declared a quarterly base cash dividend of $0.15 per share of Class A common stock, or $0.60 per share on an annualized basis. The base dividend is payable on December 31, 2025 to shareholders of record as of December 17, 2025. About Permian Resources Headquartered in Midland, Texas, Permian Resources is an independent oil and natural gas company focused on driving peer-leading returns through the acquisition, optimization and development of high-return oil and natural gas properties. The Company's assets are located in the Permian Basin, with a concentration in the c

    11/5/25 4:02:00 PM ET
    $PR
    Oil & Gas Production
    Energy

    $CYRN
    $INFI
    $LHDX
    $NEO
    Leadership Updates

    Live Leadership Updates

    View All

    NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue

    – Anticipates preliminary unaudited fourth quarter 2025 revenue of approximately $190 million; full-year 2025 revenue of $727 million – – Announces Chief Financial Officer transition – NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced preliminary fourth quarter and full-year 2025 revenue and also announced a transition of the Company's Chief Financial Officer. Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue For the fourth quarter of 2025, NeoGenomics expects to report total revenue of approximately $190 million, representing year-over-year growth of 11%. For the full-year 2025, Neo

    1/12/26 7:05:00 AM ET
    $NEO
    Precision Instruments
    Health Care

    NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. "Jack" Kenny to its Board of Directors

    NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the appointment of diagnostics and lab services industry veteran John P. "Jack" Kenny to its Board of Directors. Mr. Kenny is filling the seat vacated by Alison Hannah, MD, who is rotating off the Board after more than ten years of dedicated service. Mr. Kenny brings to the NeoGenomics Board over three decades of diverse executive, commercial, and operational experience and a track record of success in the diagnostics and lab services businesses. He most recently served as President, Chief Executive Officer and Board Director of Meridian Bioscience, a fully i

    12/30/25 7:05:00 AM ET
    $NEO
    Precision Instruments
    Health Care

    NeoGenomics Appoints Dr. Marjorie Green to Board of Directors

    NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the appointment of Marjorie Green to its Board of Directors, effective June 19, 2025. Dr. Green is currently Senior Vice President and Head of Oncology, Global Clinical Development at Merck. Dr. Green, a seasoned executive with extensive experience in the life sciences industry, brings a strong track record of leadership in oncology, corporate strategy, and business development. As Head of Oncology, Global Clinical Development at Merck, a premier biopharmaceutical company, she oversees the company's research for its single biggest area of commercial revenue a

    6/24/25 7:05:00 AM ET
    $NEO
    Precision Instruments
    Health Care